RPRX vs UHS · P/E 15, rev $1.30B vs P/E 5.9, rev $9.13B
Royalty Pharma Plc (RPRX) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
RPRX currently screens at market cap $20.45B and trailing P/E 14.8. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the RPRX and UHS stock pages for the full models.
Not investment advice.